ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
81 hedge funds and large institutions have $140M invested in Elevation Oncology in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
38% less capital invested
Capital invested by funds: $226M → $140M (-$85.3M)
67% less call options, than puts
Call options by funds: $2K | Put options by funds: $6K
Holders
81
Holding in Top 10
3
Calls
$2K
Puts
$6K
Top Buyers
| 1 | +$7.99M | |
| 2 | +$7.7M | |
| 3 | +$6.26M | |
| 4 |
Morgan Stanley
New York
|
+$3.36M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.39M |
Top Sellers
| 1 | -$4.56M | |
| 2 | -$4.56M | |
| 3 | -$4.13M | |
| 4 |
Millennium Management
New York
|
-$3.43M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.54M |